Article Text
Abstract
Background: There is ample evidence of important symptomatic efficacy of tumour necrosis factor α (TNFα) inhibition in ankylosing spondylitis (AS). Moreover, studies suggest that anti-TNF could be considered as the first disease controlling antirheumatic treatment (DC-ART) for AS.
Objective: To determine precisely which patients with AS are most likely to benefit from anti-TNFα treatment because of the cost and possible long term side effects of such treatment.
Methods: Assessment in Ankylosing Spondylitis (ASAS) members were asked to use a Delphi technique to name the characteristics of patients with AS for whom they would start DC-ART, in three different clinical presentations (isolated axial involvement, peripheral arthritis, enthesitis).
Results: Among the 62 invited ASAS members, more than 50% actively participated in the four phases of definition according to the Delphi technique. For each of the three clinical presentations, a combination of five to six domains was proposed, with an evaluation instrument and a cut off point defining a minimum level of activity for each domain.
Conclusion: This study provides a profile for a patient with AS for considering initiation of biological agents that reflects the opinion of the ASAS members, using a Delphi exercise. Further studies are required to assess their relevance and their consistency with clinical practice.
- ASAS Working Group
- ankylosing spondylitis
- tumour necrosis factor α
- biological agents
- AS, ankylosing spondylitis
- ASAS, ASsessment in Ankylosing Spondylitis
- BASFI, Bath Ankylosing Spondylitis Functional Index
- CRP, C reactive protein
- DC-ART, disease controlling antirheumatic treatment
- ESR, erythrocyte sedimentation rate
- NSAIDs, non-steroidal anti-inflammatory drugs
- TNFα, tumour necrosis factor α
- VAS, visual analogue scale
Statistics from Altmetric.com
- AS, ankylosing spondylitis
- ASAS, ASsessment in Ankylosing Spondylitis
- BASFI, Bath Ankylosing Spondylitis Functional Index
- CRP, C reactive protein
- DC-ART, disease controlling antirheumatic treatment
- ESR, erythrocyte sedimentation rate
- NSAIDs, non-steroidal anti-inflammatory drugs
- TNFα, tumour necrosis factor α
- VAS, visual analogue scale
Footnotes
-
Department and institution to which the work should be attributed: René Descartes University, AP-HP, Rheumatology B Department, Cochin Hospital, 27 rue du Faubourg Saint-Jacques, 75014 Paris, France
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.